Xencor to Participate at Upcoming March 2026 Investor Conferences
Tuesday, February 24, 2026 1 min read
Key Takeaway: Xencor, Inc. has announced its participation in several investor conferences scheduled for March 2026. The company, which focuses on developing engineered antibodies for cancer and autoimmune diseases, will provide live webcasts of the presentations. Replays will be available on their website for 30 days post-event.
Price reaction · baseline $11.57 (2026-02-23 close) · hit pre-market · 1 other XNCR headline(s) in the window, move may be shared
day 0 close
+2.1%
Market Sentiment Analysis
POSITIVE FACTORS
Xencor is actively participating in multiple investor conferences.
The company is advancing its clinical-stage biopharmaceutical developments.
Xencor's XmAb technology is being utilized in over 20 clinical candidates.
Full Press Release Details
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that company management will participate at multiple upcoming investor conferences:
Live webcasts of the presentations will be available under “Events & Presentations” in the Investors section of the Company’s website located atwww.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.
About Xencor
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and multiple XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein’s structure that result in new mechanisms of therapeutic action. For more information, please visitwww.xencor.com.
Frequently Asked Questions
What is Xencor's focus in biopharmaceuticals?
Xencor focuses on developing engineered antibodies for cancer and autoimmune diseases.
When will Xencor participate in investor conferences?
Xencor will participate in multiple investor conferences in March 2026.
Where can I watch Xencor's conference presentations?
Live webcasts of the presentations will be available on Xencor's website.
How long will the replays of the events be available?
Replays of the events will be available for at least 30 days after the presentations.